Drug · DIN 02452995
BRIVLERA
SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 10, 2018; first marketed October 10, 2018.
- Drug Identification Number (DIN)
- 02452995
- Company (DIN owner)
- Ucb Canada IncOakville, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Brivaracetam N03AX23
- Class
- Human
- Record last updated
- August 7, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BRIVARACETAM | 10 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 9, 2016: NOC 17859New Drug Submission (NDS)
Other DINs named BRIVLERA
- DIN 02452936 · Marketed
- DIN 02452944 · Marketed
- DIN 02452952 · Marketed
- DIN 02452960 · Marketed
- DIN 02452979 · Marketed
- DIN 02452987 · Marketed